Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

DepoCyt

Known as: Depo-Cyt, DepoFoam Encapsulated Cytarabine 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Pain following orthopedic surgery is common and often suboptimally managed, with many patients reporting acute moderate to severe… Expand
Highly Cited
2012
Highly Cited
2012
Treatment of leptomeningeal metastasis (LMD) remains challenging due to advanced systemic disease at presentation and limited… Expand
  • table 1
  • table 2
  • table 3
Highly Cited
2006
Highly Cited
2006
SummaryIntroductionCytarabine liposome injection (DepoCyt®), a sterile suspension of the antimetabolite cytarabine, encapsulated… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
Review
2006
Review
2006
Lamellar liposome technology has been used for several decades to produce sustained-release drug formulations for parenteral… Expand
Highly Cited
2004
Highly Cited
2004
Drugs currently available for intrathecal administration are cleared rapidly from the CSF. DepoCyt is a slow-release formulation… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2004
Highly Cited
2004
PURPOSE We performed a phase I trial of intrathecal (IT) liposomal cytarabine (DepoCyt; Enzon Pharmaceuticals, Piscataway, NJ and… Expand
2003
2003
Part I: Pharmacological Considerations for Drug Delivery Systems in Cancer Medicine Systemically Administered Drugs Reginald B… Expand
2003
2003
Encapsulation of drugs into multivesicular liposomes (Depofoam) offers a novel approach to sustained release drug delivery… Expand
  • figure 2
  • figure 1
  • table 1
Highly Cited
1999
Highly Cited
1999
Standard treatment for neoplastic meningitis requires frequent intrathecal (IT) injections of chemotherapy and is only modestly… Expand
  • figure 1
  • table 2
  • table 1
  • figure 2
  • figure 3
Highly Cited
1999
Highly Cited
1999
PURPOSE To evaluate the efficacy and safety of a slow-release formulation of cytarabine (DepoCyt; Chiron Corp, Emeryville, CA… Expand